Ibogaine Research and Transcend in the News
Schedule Free Consultation →Science First is how we work. This page collects published research on ibogaine and the research we take part in, with links to the original sources so you can read them yourself.
University of Ottawa research visit to Transcend

Tabaret Hall, University of Ottawa. Photo: RobCA, public domain, via Wikimedia Commons.

A University of Ottawa team led by Dr. Monnica Williams spent a week at Transcend Clinic in Cancún observing screening, monitoring and care. Read the press release on USA Today (Oct 5, 2026) and our own account, Why We Opened Transcend Clinic to Ottawa Researchers.

Researchers discuss their work during a week-long visit to Transcend Clinic in Cancún, Mexico.
The Stanford Medicine study
In January 2024, researchers at Stanford Medicine published a study in Nature Medicine of U.S. special operations veterans with traumatic brain injuries. The veterans received ibogaine treatment at Ambio Life Sciences in Mexico, not at Transcend. Transcend was not part of this study. Read the study at its source: Nature Medicine.
Federal interest in ibogaine research
Psychedelic Alpha reported on the ARPA-H workshop exploring next steps for ibogaine research (Sep 17, 2026). Read on Psychedelic Alpha
Scientia Prima: conversations with our physicians
Our video series with Dr. Fernando Rivas and the medical team covers why screening comes first. Watch the series on our YouTube channel.
Transcend in the news
Coverage includes WBOC 16, KDH News and Lincoln Journal, and the second-anniversary release. See every story on In the News.
Read more on our blog
Articles in the Research & Science category of The Transcend Journal.
Ready to Begin Your Journey?
Free, confidential consultation with our medical team.
Schedule Free Consultation →